comparemela.com

Latest Breaking News On - Bernstein capital management - Page 1 : comparemela.com

Greenwich Investment Management Inc. Sells 189 Shares of NVE Co. (NASDAQ:NVEC)

Greenwich Investment Management Inc. trimmed its stake in NVE Co. (NASDAQ:NVEC – Free Report) by 1.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 15,620 shares of the semiconductor company’s stock after selling 189 shares during the quarter. NVE makes […]

United-states
Greenwich-investment-management-inc
Silverberg-bernstein-capital-management
Vanguard-group-inc
Nasdaq
Penserra-capital-management
Securities-exchange-commission
Aviva-plc
Citigroup-inc
Greenwich-investment-management
Free-report

Homestead Advisers Corp Purchases New Stake in Lantheus Holdings, Inc. (NASDAQ:LNTH)

Homestead Advisers Corp purchased a new stake in Lantheus Holdings, Inc. (NASDAQ:LNTH – Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 31,600 shares of the medical equipment provider’s stock, valued at approximately $1,959,000. Several other institutional investors have also recently […]

Boston
Massachusetts
United-states
Daniel-niedzwiecki
Andrea-sabens
Clearbridge-investments
Dakota-investment-council
Lantheus-holdings-inc
Homestead-advisers-corp
Lantheus-company-profile
Exchange-commission
Silverberg-bernstein-capital-management

Pharming Group (NASDAQ:PHAR) Reaches New 52-Week Low at $7.68

Shares of Pharming Group (NASDAQ:PHAR – Get Free Report) reached a new 52-week low on Wednesday . The stock traded as low as $7.68 and last traded at $7.68, with a volume of 18232 shares. The stock had previously closed at $8.75. Analyst Ratings Changes Separately, HC Wainwright reiterated a “buy” rating and set a […]

United-states
Pharming-group-trading-down
Hedge-funds-weigh-in-on-pharming-group
Securities-exchange-commission
Pharming-group
News-ratings-for-pharming-group-daily
Silverberg-bernstein-capital-management
Get-free-report
Group-trading-down
Bernstein-capital-management
Free-report

Pharming Group (NASDAQ:PHAR) Reaches New 52-Week Low at $7.68

Shares of Pharming Group (NASDAQ:PHAR – Get Free Report) reached a new 52-week low on Wednesday . The stock traded as low as $7.68 and last traded at $7.68, with a volume of 18232 shares. The stock had previously closed at $8.75. Analyst Ratings Changes Separately, HC Wainwright reiterated a “buy” rating and set a […]

United-states
Securities-exchange-commission
Pharming-group
News-ratings-for-pharming-group-daily
Silverberg-bernstein-capital-management
Pharming-group-trading-down
Hedge-funds-weigh-in-on-pharming-group
Get-free-report
Group-trading-down
Bernstein-capital-management
Free-report

VolitionRx (NYSE:VNRX) Receives New Coverage from Analysts at StockNews.com

StockNews.com initiated coverage on shares of VolitionRx (NYSE:VNRX – Free Report) in a research report sent to investors on Tuesday morning. The firm issued a sell rating on the stock. Separately, Cantor Fitzgerald reissued an overweight rating and issued a $2.50 price target on shares of VolitionRx in a report on Thursday, May 16th. Get […]

United-states
Silverberg-bernstein-capital-management
Exchange-commission
Volitionrx-limited
Cantor-fitzgerald
Free-report
Get-free-report
Bernstein-capital-management
Volitionrx-daily

vimarsana © 2020. All Rights Reserved.